Global Dementia and Movement Disorder Treatment Market Research Report 2023

Report ID: 1974064 | Published Date: Sep 2024 | No. of Page: 94 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 MAO Inhibitors (Monoamine Oxidase)
        1.2.3 AChE Inhibitors (Acetylcholinesterase)
        1.2.4 Glutamate Inhibitors
    1.3 Market by Application
        1.3.1 Global Dementia and Movement Disorder Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Dementia and Movement Disorder Treatment Market Perspective (2017-2028)
    2.2 Dementia and Movement Disorder Treatment Growth Trends by Region
        2.2.1 Dementia and Movement Disorder Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Dementia and Movement Disorder Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Dementia and Movement Disorder Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Dementia and Movement Disorder Treatment Market Dynamics
        2.3.1 Dementia and Movement Disorder Treatment Industry Trends
        2.3.2 Dementia and Movement Disorder Treatment Market Drivers
        2.3.3 Dementia and Movement Disorder Treatment Market Challenges
        2.3.4 Dementia and Movement Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Dementia and Movement Disorder Treatment Players by Revenue
        3.1.1 Global Top Dementia and Movement Disorder Treatment Players by Revenue (2017-2022)
        3.1.2 Global Dementia and Movement Disorder Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Dementia and Movement Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Dementia and Movement Disorder Treatment Revenue
    3.4 Global Dementia and Movement Disorder Treatment Market Concentration Ratio
        3.4.1 Global Dementia and Movement Disorder Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Dementia and Movement Disorder Treatment Revenue in 2021
    3.5 Dementia and Movement Disorder Treatment Key Players Head office and Area Served
    3.6 Key Players Dementia and Movement Disorder Treatment Product Solution and Service
    3.7 Date of Enter into Dementia and Movement Disorder Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Dementia and Movement Disorder Treatment Breakdown Data by Type
    4.1 Global Dementia and Movement Disorder Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Dementia and Movement Disorder Treatment Forecasted Market Size by Type (2023-2028)
5 Dementia and Movement Disorder Treatment Breakdown Data by Application
    5.1 Global Dementia and Movement Disorder Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Dementia and Movement Disorder Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Dementia and Movement Disorder Treatment Market Size (2017-2028)
    6.2 North America Dementia and Movement Disorder Treatment Market Size by Country (2017-2022)
    6.3 North America Dementia and Movement Disorder Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Dementia and Movement Disorder Treatment Market Size (2017-2028)
    7.2 Europe Dementia and Movement Disorder Treatment Market Size by Country (2017-2022)
    7.3 Europe Dementia and Movement Disorder Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Dementia and Movement Disorder Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Dementia and Movement Disorder Treatment Market Size (2017-2028)
    9.2 Latin America Dementia and Movement Disorder Treatment Market Size by Country (2017-2022)
    9.3 Latin America Dementia and Movement Disorder Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Dementia and Movement Disorder Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Dementia and Movement Disorder Treatment Introduction
        11.1.4 Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Dementia and Movement Disorder Treatment Introduction
        11.2.4 Novartis Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Dementia and Movement Disorder Treatment Introduction
        11.3.4 Roche Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Teva
        11.4.1 Teva Company Detail
        11.4.2 Teva Business Overview
        11.4.3 Teva Dementia and Movement Disorder Treatment Introduction
        11.4.4 Teva Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.4.5 Teva Recent Development
    11.5 Amgen
        11.5.1 Amgen Company Detail
        11.5.2 Amgen Business Overview
        11.5.3 Amgen Dementia and Movement Disorder Treatment Introduction
        11.5.4 Amgen Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.5.5 Amgen Recent Development
    11.6 UCB
        11.6.1 UCB Company Detail
        11.6.2 UCB Business Overview
        11.6.3 UCB Dementia and Movement Disorder Treatment Introduction
        11.6.4 UCB Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.6.5 UCB Recent Development
    11.7 H. Lundbeck
        11.7.1 H. Lundbeck Company Detail
        11.7.2 H. Lundbeck Business Overview
        11.7.3 H. Lundbeck Dementia and Movement Disorder Treatment Introduction
        11.7.4 H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.7.5 H. Lundbeck Recent Development
    11.8 Eli Lilly
        11.8.1 Eli Lilly Company Detail
        11.8.2 Eli Lilly Business Overview
        11.8.3 Eli Lilly Dementia and Movement Disorder Treatment Introduction
        11.8.4 Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.8.5 Eli Lilly Recent Development
    11.9 Allergan
        11.9.1 Allergan Company Detail
        11.9.2 Allergan Business Overview
        11.9.3 Allergan Dementia and Movement Disorder Treatment Introduction
        11.9.4 Allergan Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.9.5 Allergan Recent Development
    11.10 Eisai
        11.10.1 Eisai Company Detail
        11.10.2 Eisai Business Overview
        11.10.3 Eisai Dementia and Movement Disorder Treatment Introduction
        11.10.4 Eisai Revenue in Dementia and Movement Disorder Treatment Business (2017-2022)
        11.10.5 Eisai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of MAO Inhibitors (Monoamine Oxidase)
    Table 3. Key Players of AChE Inhibitors (Acetylcholinesterase)
    Table 4. Key Players of Glutamate Inhibitors
    Table 5. Global Dementia and Movement Disorder Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Dementia and Movement Disorder Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Dementia and Movement Disorder Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Dementia and Movement Disorder Treatment Market Share by Region (2017-2022)
    Table 9. Global Dementia and Movement Disorder Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Dementia and Movement Disorder Treatment Market Share by Region (2023-2028)
    Table 11. Dementia and Movement Disorder Treatment Market Trends
    Table 12. Dementia and Movement Disorder Treatment Market Drivers
    Table 13. Dementia and Movement Disorder Treatment Market Challenges
    Table 14. Dementia and Movement Disorder Treatment Market Restraints
    Table 15. Global Dementia and Movement Disorder Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Dementia and Movement Disorder Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Dementia and Movement Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Movement Disorder Treatment as of 2021)
    Table 18. Ranking of Global Top Dementia and Movement Disorder Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Dementia and Movement Disorder Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Dementia and Movement Disorder Treatment Product Solution and Service
    Table 22. Date of Enter into Dementia and Movement Disorder Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Dementia and Movement Disorder Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Dementia and Movement Disorder Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Dementia and Movement Disorder Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Dementia and Movement Disorder Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Dementia and Movement Disorder Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Dementia and Movement Disorder Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Dementia and Movement Disorder Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Dementia and Movement Disorder Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Dementia and Movement Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Dementia and Movement Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Dementia and Movement Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Dementia and Movement Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Dementia and Movement Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Dementia and Movement Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Pfizer Company Detail
    Table 43. Pfizer Business Overview
    Table 44. Pfizer Dementia and Movement Disorder Treatment Product
    Table 45. Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 46. Pfizer Recent Development
    Table 47. Novartis Company Detail
    Table 48. Novartis Business Overview
    Table 49. Novartis Dementia and Movement Disorder Treatment Product
    Table 50. Novartis Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 51. Novartis Recent Development
    Table 52. Roche Company Detail
    Table 53. Roche Business Overview
    Table 54. Roche Dementia and Movement Disorder Treatment Product
    Table 55. Roche Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 56. Roche Recent Development
    Table 57. Teva Company Detail
    Table 58. Teva Business Overview
    Table 59. Teva Dementia and Movement Disorder Treatment Product
    Table 60. Teva Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 61. Teva Recent Development
    Table 62. Amgen Company Detail
    Table 63. Amgen Business Overview
    Table 64. Amgen Dementia and Movement Disorder Treatment Product
    Table 65. Amgen Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 66. Amgen Recent Development
    Table 67. UCB Company Detail
    Table 68. UCB Business Overview
    Table 69. UCB Dementia and Movement Disorder Treatment Product
    Table 70. UCB Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 71. UCB Recent Development
    Table 72. H. Lundbeck Company Detail
    Table 73. H. Lundbeck Business Overview
    Table 74. H. Lundbeck Dementia and Movement Disorder Treatment Product
    Table 75. H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 76. H. Lundbeck Recent Development
    Table 77. Eli Lilly Company Detail
    Table 78. Eli Lilly Business Overview
    Table 79. Eli Lilly Dementia and Movement Disorder Treatment Product
    Table 80. Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 81. Eli Lilly Recent Development
    Table 82. Allergan Company Detail
    Table 83. Allergan Business Overview
    Table 84. Allergan Dementia and Movement Disorder Treatment Product
    Table 85. Allergan Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 86. Allergan Recent Development
    Table 87. Eisai Company Detail
    Table 88. Eisai Business Overview
    Table 89. Eisai Dementia and Movement Disorder Treatment Product
    Table 90. Eisai Revenue in Dementia and Movement Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 91. Eisai Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dementia and Movement Disorder Treatment Market Share by Type: 2021 VS 2028
    Figure 2. MAO Inhibitors (Monoamine Oxidase) Features
    Figure 3. AChE Inhibitors (Acetylcholinesterase) Features
    Figure 4. Glutamate Inhibitors Features
    Figure 5. Global Dementia and Movement Disorder Treatment Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Dementia and Movement Disorder Treatment Report Years Considered
    Figure 10. Global Dementia and Movement Disorder Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Dementia and Movement Disorder Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Dementia and Movement Disorder Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Dementia and Movement Disorder Treatment Market Share by Players in 2021
    Figure 14. Global Top Dementia and Movement Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Movement Disorder Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Dementia and Movement Disorder Treatment Revenue in 2021
    Figure 16. North America Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Dementia and Movement Disorder Treatment Market Share by Country (2017-2028)
    Figure 18. United States Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Dementia and Movement Disorder Treatment Market Share by Country (2017-2028)
    Figure 22. Germany Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Dementia and Movement Disorder Treatment Market Share by Region (2017-2028)
    Figure 30. China Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Dementia and Movement Disorder Treatment Market Share by Country (2017-2028)
    Figure 38. Mexico Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Dementia and Movement Disorder Treatment Market Share by Country (2017-2028)
    Figure 42. Turkey Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Dementia and Movement Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Pfizer Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 47. Teva Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 48. Amgen Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 49. UCB Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 50. H. Lundbeck Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 51. Eli Lilly Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 52. Allergan Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 53. Eisai Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Roche
Teva
Amgen
UCB
H. Lundbeck
Eli Lilly
Allergan
Eisai
Frequently Asked Questions
Dementia and Movement Disorder Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dementia and Movement Disorder Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dementia and Movement Disorder Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dental Adhesives

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Dental CAD-CAM

Dental CAD-CAM market is segmented by players, region (country), by Type and by Application. Play ... Read More